Test May Reduce Post-Transplant Biopsies.
In: New York Times, Jg. 159 (2010-04-23), Heft 55019, S. 5-5
Online
Zeitungsartikel
Zugriff:
A blood test that analyzes genetic activity could let heart transplant patients avoid many of the invasive and uncomfortable biopsies now used to monitor whether their immune systems are rejecting their new organs, doctors said in a study published Thursday. The study found that patients who were monitored for rejection using the blood test had outcomes roughly equivalent to those of patients who were given frequent heart biopsies. The test, called AlloMap, was developed by XDx, a privately held company in Brisbane, Calif. [ABSTRACT FROM PUBLISHER]
Titel: |
Test May Reduce Post-Transplant Biopsies.
|
---|---|
Autor/in / Beteiligte Person: | Pollack, Andrew |
Link: | |
Zeitschrift: | New York Times, Jg. 159 (2010-04-23), Heft 55019, S. 5-5 |
Veröffentlichung: | 2010 |
Medientyp: | Zeitungsartikel |
ISSN: | 0362-4331 (print) |
Schlagwort: |
|
Sonstiges: |
|